low blood pressure on tirzepatide Systolic reduction with in patients with type 2 diabetes: insights from SURPASS clinical program | Cardiovascular Diabetology Retatrutide and High Blood Pressure:

So far, serious side effects havent been common, but heres what an early phase 2 study has shown: Pancreatitis: Happened in about 0.4% of people in the study Gallbladder problems: Reported in about 1.1% of participants Heart rhythm changes: Seen more often with retatrutide, about 6% compared to 3% with placebo Liver enzyme changes: Around 1% of participants had increases, but overall liver health stayed stable These results suggest a low but real chance of serious issues such as pancreatitis, gallbladder problems, severe GI events, and allergic reactions

The median time from initiation of semaglutide to the most recent HbA1c measurement was 928 days (IQR 2161,343

Most individuals regain this weight within subsequent months as normal eating patterns resume

These factors can affect accuracy, sensitivity, and reproducibility of results